Cwm, LLC Tenaya Therapeutics, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 29 shares of TNYA stock, worth $106. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 21 38.1%

Holding current value

$106

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$1.93 - $3.99 $15 - $31	8 Added 38.1%	29 $0
Q2 2024 Jul 09, 2024	BUY	$2.72 - $4.99 $54 - $99	20 Added 2000.0%	21 $0
Q1 2024 Apr 05, 2024	BUY	$2.88 - $6.8 $2 - $6	1 New	1 $0

Others Institutions Holding TNYA

# of Institutions

Shares Held

56.3M

Call Options Held

900

Put Options Held

400

Column Group LLC San Francisco, CA

9.4M
Shares

$34.4 Million
26.09% of portfolio
Ra Capital Management, L.P. Boston, MA

6.98M
Shares

$25.6 Million
0.19% of portfolio
Casdin Capital, LLC New York, NY

6.73M
Shares

$24.6 Million
1.01% of portfolio
Black Rock Inc. New York, NY

4.07M
Shares

$14.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.21M
Shares

$11.8 Million
0.0% of portfolio

View Full List

About Tenaya Therapeutics, Inc.

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $151M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

More about TNYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account